Haemonetics (HAE) Other Gross PP&E Adjustments (2010 - 2026)

Haemonetics has reported Other Gross PP&E Adjustments for 17 years, with the latest figure at $802.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 1.58% year-over-year to $802.2 million; the trailing twelve-month figure through Mar 2026 stood at $802.2 million (up 1.58% YoY), and the FY2026 full-year result was $802.2 million, up 1.58% from the prior year.
• Other Gross PP&E Adjustments for Q1 2026 stood at $802.2 million, down from $824.5 million in the prior quarter.
• The five-year high for Other Gross PP&E Adjustments was $967.1 million in Q4 2023, with the low at $756.0 million in Q2 2025.
• Average Other Gross PP&E Adjustments over 5 years is $875.3 million, with a median of $889.3 million recorded in 2022.
• Year-over-year, Other Gross PP&E Adjustments gained 8.64% in 2023 and decreased 17.67% in 2025.
• Tracing HAE's Other Gross PP&E Adjustments over 5 years: stood at $869.1 million in 2022, then climbed by 11.27% to $967.1 million in 2023, then slipped by 11.65% to $854.5 million in 2024, then dropped by 3.51% to $824.5 million in 2025, then dropped by 2.7% to $802.2 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at $802.2 million (Q1 2026), $824.5 million (Q4 2025), and $790.4 million (Q3 2025), per Business Quant data.

Peer Comparison